Raute’s Q3 revenue was meaningfully lower than we estimated, yet absolute profitability figures were...
Solteq’s Q3 results were as expected rather weak but revenue turned to growth in comparable terms an...
Redeye comments on the improvements made on the circVec platform.
Redeye provides its initial take on Mentice’s Q3 2023 report, which featured stronger top-line growt...
Redeye comments on Gapwaves Q3 2023 report which came in below expectations.
ARR +9% y-o-y, in line with ABGSCe Outlook unchanged despite a tougher market Cons.
Redeye is positive towards the top-line data from the phase Ia trial with HER-096 presented by Heran...
Redeye comments on Carasent's Q3 2023 report, which was heavily influenced by lower consulting reven...
Redeye see's an uplifting Q3 2023 report from Stille, which came in above our estimates both in term...
Sales +2% and adj. EBITDA +16% vs. ABGSCe Operating cash flow 100% above ABGSCe Restructuring effort...
Redeye states that the Q3 report was good, though not as good as Redeye had expected.
NOI +0% and rec PTP +3% vs ABGSCe EC IFPM +33% q-o-q and +2% vs ABGSC 2024e Net LTV down to 27.
Redeye comments on Artificial Solutions (AS) Q3’2023 report.
Redeye provides its initial take on ADDvise’s Q3 2023 report, which came in broadly above our estima...
Revenue guidance raised to DKK 10bn from DKK 9.0 - 9.
Redeye comments on Evolution’s Q3-results which came in slightly below our expectations owing to low...
CapMan reported Q3 EBIT of EUR 4.8m, clearly below Refinitiv consensus at EUR 7m.
Redeye updates on Stillfront following its Q3-results which came in below our expectations.
Sales +2% vs. ABGSCe, adj. EBIT +12% vs. ABGSCe Lowers '25 targets and initiaties cost savings progr...
Redeye leaves a comment on yesterday’s news that Jesper Wiklund is stepping down as the CEO of Klari...
